Cardio-Kidney-Damage: A unifying concept

Kidney International

Volumn 78, Issue 1, 2010, Pages 14-18

  Nahas, Meguid El ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cardio kidney damage; Cardiovascular disease; Chronic kidney disease; CKD; CVD

Indexed keywords

AGING; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE MARKER; GLOMERULUS FILTRATION RATE; HEART INJURY; HUMAN; KIDNEY INJURY; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; AGED; ALBUMINURIA; KIDNEY; KIDNEY FAILURE, CHRONIC; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK; TREATMENT OUTCOME;

AGED; ALBUMINURIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK; TREATMENT OUTCOME;

EID: 77953686335     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.123     Document Type: Article

References (33)

1. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047. (Pubitemid 350074801)
2. World Health Organization. The World Health Report 2006: Working Together for Health. WHO: Geneva, 2006.
3. National Kidney Foundation. K/DOQI kidney disease outcome quality initiative. Am J Kidney Dis 2002; 39(Suppl. 1): S1-S266.
4. Hillege HL, Janssen WM, Bak AA, et al., Prevend Study Group. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249: 519-526.
5. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
6. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic kidney disease. Kidney Int 2009; 75: 1009-1014.
7. Liese AD, Hense HW, Döring A et al. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens 2001; 15: 799-804.
8. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174.
9. Bello AK, de Zeeuw D, El Nahas M et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant 2007; 22: 1619-1627.
10. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007; 2: 581-590.
11. Verhave JC, Fesler P, Ribstein J et al. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005; 46: 233-241.
12. Stevens PE, O'Donoghue DJ, de Lusignan S et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; 72: 92-99.
13. Melamed ML, Bauer C, Hostetter TH. eGFR: is it ready for early identification of CKD? Clin J Am Soc Nephrol 2008; 3: 1569-1572.
14. World Population Ageing 1950-2050. United Nations Report.
15. Christensen K, Doblhammer G, Rau R et al. Ageing populations: the challenges ahead. Lancet 2009; 374: 1196-1208.
16. Burt VL, Whelton P, Roccella EJ et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
17. Danaei G, Friedman AB, Oza S et al. Diabetes prevalence and diagnosis in US states: analysis of health surveys. Popul Health Metr 2009; 7: 16.
18. Ishikawa T, Hashimoto J, Morito RH et al. Association of microalbuminuria with brachial-ankle pulse wave velocity: the Ohasama study. Am J Hypertens 2008; 21: 413-418.
19. Hermans MM, Henry R, Dekker JM et al. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol 2007; 18: 1942-1952.
20. Mahmoodi BK, Gansevoort RT, Veeger NJ, et al., Prevention of Renal and Vascular End-stage Disease (PREVEND) Study Group. Microalbuminuria and risk of venous thromboembolism. JAMA 2009; 301: 1790-1797.
21. Cao JJ, Barzilay JI, Peterson D et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study. Atherosclerosis 2006; 187: 372-377.
22. Smilde TD, Damman K, Van der Harst P et al. Differential associations between renal function and 'modifiable' risk factors in patients with chronic heart failure. Clin Res Cardiol 2009; 98: 121-129.
23. Garg AX, Kiberd BA, Clark WF et al. Albuminuria and renal insufficiency prevalence guides population screening: results from the III NHANES. Kidney Int 2002; 61: 2165-2175.
24. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285.
25. Chonchol M, Gnahn H, Sander D. Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly. Nephrol Dial Transplant 2008; 23: 2593-2598.
26. Wu CK, Yang CY, Tsai CT et al. Association of low glomerular filtration rate and albuminuria with peripheral arterial disease: The National Health and Nutrition Examination Survey, 1999-2004. Atherosclerosis 2010; 209: 230-234.
27. Kshirsagar AV, Bang H, Bomback AS et al. A simple algorithm to predict incident kidney disease. Arch Intern Med 2008; 168: 2466-2473.
28. Shlipak MG, Katz R, Kestnbaum B et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis 2009; 204: 298-303.
29. Yusuf S, Pais P, Afzal R et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009; 373: 1341-1351.
30. Wald NJ, Wald DS. The polypill concept. Heart 2010; 96: 1-4.
31. Jackson CE, Solomon SD, Gerstein HC et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009; 374: 543-550.
32. Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559.
33. Ahmed AK, Kamath NS, El Kossi M et al. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant, 10 October, 2009.